EP05.01-007. CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)
Back to course
Pdf Summary
Asset Subtitle
Gerard M Walls
Meta Tag
Speaker Gerard M Walls
Topic Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
Keywords
CONCORDE study
Phase Ib
DNA damage response inhibitors
radiotherapy
non-small cell lung cancer
safety
recommended phase II dose
clinical trial
translational program
toxicity biomarkers
Powered By